Carmat S.A. (CKMTF)
Carmat S.A. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Vélizy-Villacoublay, FR. The stock last traded at $12.75, down 50.96% on the session, giving a market capitalisation of $85.2M. On trailing twelve-month figures it carries a trailing P/E of -5.13, a net margin of -1925.0%. Its beta of 1.38 implies it has historically moved more than the broad market.
Carmat S.A. is dedicated to engineering and producing cutting-edge total artificial hearts. These innovative devices are developed to aid patients afflicted with severe, end-stage biventricular heart failure, serving markets in France and across the globe. The company was established in 2008 and operates from its primary base in Vélizy-Villacoublay, France.
Carmat S.A. is most often compared with the following Healthcare names: